Helena A. Feenstra
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Long-Term Follow-Up of PLACE and SPECTRA Trials: Outcomes After Successful and Unsuccessful Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
Journal: American journal of ophthalmology
Published: November 07, 2025
Risk factors for the development of subretinal fluid in the fellow eyes of patients with chronic central serous chorioretinopathy.
Journal: Acta ophthalmologica
Published: September 09, 2025
Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4.
Journal: Acta ophthalmologica
Published: May 27, 2025
Analysis of optical coherence tomography biomarker probability detection in central serous chorioretinopathy by using an artificial intelligence-based biomarker detector.
Journal: International journal of retina and vitreous
Published: April 19, 2024
BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY.
Journal: Retina (Philadelphia, Pa.)
Published: October 26, 2023
Central serous chorioretinopathy: An evidence-based treatment guideline.
Journal: Progress in retinal and eye research
Published: September 12, 2023
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Journal: Retina (Philadelphia, Pa.)
Published: February 02, 2023
SINGLE-SESSION BILATERAL REDUCED-SETTINGS PHOTODYNAMIC THERAPY FOR BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Journal: Retina (Philadelphia, Pa.)
Published: January 09, 2023
Argon laser photocoagulation in polypoidal choroidal vasculopathy.
Journal: Clinical & experimental ophthalmology
Published: October 28, 2022
Comparative efficacy of treatments for chronic central serous chorioretinopathy: A systematic review with network meta-analyses.
Journal: Acta ophthalmologica
Published: August 06, 2022
Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: June 11, 2022
Last Updated: 09/26/2026